Ventive Hospitality

With a ₹ 2,000 crore expansion, Ventive Hospitality aims to capitalize on luxury travel demand. The firm operates 13 assets and plans to grow by focusing on large luxury projects and acquisitions in key markets like Goa, Sri Lanka and the Maldives.

India is a key growth market for Marriott in Asia Pacific, with strong demand in corporate travel and weddings boosting prospects. Here's why Neeraj Govil, chief operating officer for the region calls India an absolute powerhouse for the company.

Ventive Hospitality and Marriott will add six new hotels in India, boosting Marriott’s portfolio by 1,600 rooms. Ventive aims to double room capacity to over 4,000 in five years with a ₹ 2,500 crore investment.

India's hospitality sector is experiencing a transformation with over ₹ 10,000 crore invested in hotel companies since 2023. This surge in IPOs, mergers, and fund-raising signals investor confidence, while new management companies target smaller cities to tap rising demand for leisure travel.

The luxury hotel chain, operated by Brookfield-backed Schloss Bangalore Ltd, says it will remain a niche, pure-play luxury brand with a sharp focus on high-end hospitality, as it prepares to raise ₹ 3,500 via the public offer that opens on Monday.

Ventive Hospitality's IPO raised ₹ 1,600 crore, opening at a significant premium on the BSE. The company operates 11 luxury properties and relies heavily on third-party operators, which could pose reputational risks despite strong financial performance.

Ventive Hospitality IPO listing date is today, December 30, and the equity shares of the company will be listed on both the stock exchanges, BSE and NSE.

IPO GMP, listing date: Ventive Hospitality, Senores Pharmaceuticals, and Carraro India IPOs will list on December 30. Senores Pharmaceuticals has a 93.69 times subscription, while Ventive shows a positive grey market premium. Carraro India remains at its issue price with no premium observed.